Search for: "Files v. King et al" Results 201 - 220 of 303
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2009, 2:45 pm
The lead case before the Circuit Court was National Rifle Association, et al., v. [read post]
30 Mar 2011, 8:55 pm by Craig Robins
Steven Baum, MERSCORP, Inc., et. al., is pending here in the Eastern District of New York. [read post]
27 May 2009, 2:46 pm
King (Circuit docket 07-15763). [read post]
4 Oct 2021, 1:52 pm by Jason Rantanen
Post-AIA (Point Estimate) We thank LaTia Brand of Harrity Analytics and the Stanford NPE Database, described in Shawn Miller et al., Who’s Suing Us? [read post]
4 Oct 2021, 1:52 pm by Jason Rantanen
Post-AIA (Point Estimate) We thank LaTia Brand of Harrity Analytics and the Stanford NPE Database, described in Shawn Miller et al., Who’s Suing Us? [read post]
25 Jun 2013, 11:31 am by Mark Walsh
James Sensenbrenner et al., who filed an amicus brief in support of the respondent in this case. [read post]
7 Mar 2008, 9:46 am
Tom King, et al (NFP) - "Although it may have been preferable to consolidate both flooding instances into one lawsuit, each flooding occurrence creates a separate cause of action. [read post]
19 Jan 2023, 9:23 pm by Florian Mueller
Its in-house adjudicative proceeding does not prevent the merger from closing.This is the order on the motion to stay and the next deadlines and hearing dates:DeMartini et al. v. [read post]
21 Mar 2023, 12:12 am by Florian Mueller
" Here's the order (my commentary continues below the document, where I'll also provide an updated timeline chart):DeMartini et al. v. [read post]
30 Nov 2011, 8:19 am
Family members had served in senior positions under the kingdom’s late rulers, kings Faisal and Saud, according to the memo. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs)   Products Ablify (Aripiprazole) – US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) – US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) – US: Teva files amended complaint against Momenta/Sandoz to include… [read post]